Thallium-201 scintigraphy for the evaluation of tumor response to preoperative chemotherapy in patients with osteosarcoma

Cancer

Volumn 80, Issue 8, 1997, Pages 1507-1512

  Imbriaco, Massimo ^a   Yeh, Samuel D J ^a   Yeung, Henry ^a   Zhang, Jia Ju ^a   Healey, John H ^a   Meyers, Paul ^a   Huvos, Andrew G ^a   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Chemotherapy; Osteosarcoma; Scintigraphy; Thallium 201

Indexed keywords

THALLIUM 201;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; OSTEOSARCOMA; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; SCHOOL CHILD; SCINTISCANNING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; EVALUATION STUDIES; FEMALE; HUMANS; MALE; OSTEOSARCOMA; PREOPERATIVE CARE; THALLIUM RADIOISOTOPES;

EID: 0030833420     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19971015)80:8<1507::AID-CNCR19>3.0.CO;2-9     Document Type: Article

References (31)

1. Classer DB, Lane JM, Huvos AG, Marcove RC, Rosen G. Survival, prognosis, and therapeutic response in osteogenic sarcoma. Cancer 1992;69:698-708.
2. Meyers PA, Heller G, Healey J, Huvos A, Lane J, Marcove R, et al. Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience. J Clin Oncol 1992;10:5-15.
3. Hudson M, Jaffe MR, Jaffe N, Ayala A, Raymond K, Carrasco H, et al. Pediatric osteosarcoma: therapeutic strategies, results and prognostic factors derived from a 10-year experience. J Clin Oncol 1990;8:1988-97.
4. Aisen AM, Martel W, Braunstein EM, McMillin KI, Phillips WA, Kling TF. MRI and CT evaluation of primary bone and soft tissue tumors. Am J Roentgenol 1986;146:749-56.
5. Seeger LL, Eckardt JJ, Bassett LW. Cross sectional imaging in the evaluation of osteogenic sarcoma: MRI and CT. Semin Roentgenol 1989;24:174-84.
6. Zimmer WD, Berquist TH, McLeod RA, Sim FH, Pritchard DJ, Shives TH, et al. Bone tumors: magnetic resonance imaging versus computed tomography. Radiology 1985;155:709-18.
7. Pan G, Raymind AK, Carrasco CH, Wallace S, Kim EE, Shirkhoda A, et al. Osteosarcoma: MR imaging after preoperative chemotherapy. Radiology 1990;174:517-26.
8. McKillop JH, Etcuhanas E, Goris ML. The indications for and limitations of bone scintigraphy in osteogenic sarcomas: a review of 55 patients. Cancer 1981;48:1133-8.
9. Ramanna L, Waxman AD, Waxman S, Binney G, Brachaman MB, Tanasescu DE. Tl-201 scintigraphy in bone and soft tissue sarcoma: evaluation of tumor mass and viability. J Nucl Med 1988;29:854.
10. Terui S, Oyamada H, Nishikawa K, Beppu Y, Fukuma H. Tl-201 chloride scintigraphy for bone tumors and soft part sarcomas. J Nucl Med 1984;25:114.
11. Huvos AG, Rosen G, Marcove RC. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy, en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 1977;101:14-8.
12. Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol 1987;5:21-6.
13. Link MP, Goorin AL, Miser AW, Green AA, Pratt CB, Belasco JB, et al. The effect of adjuvant chemotherapy on relapse-free disease survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-6.
14. Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, et al. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based upon the response of the primary tumor to preoperative chemotherapy. Cancer 1982;49:1221-30.
15. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA. Pediatric musculoskeletal tumors: use of dynamic contrast-enhanced MR imaging to monitor response to chemotherapy. Radiology 1992;184:243-8.
16. Holscher HC, Bloem JL, Vanel D, Hermans J, Nooy MA, Taminiau AHM, et al. Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 1992;182:839-44.
17. Holscher HC, Bloem JL, Van Der Woude HJ, Hermans J, Nooy MA, Taminiau AHM, et al. Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 1995;50:384-90.
18. de Baere T, Vanel D, Shapeero LG, Charpentier A, Terrier P, Di Paola M. Osteosarcoma after chemotherapy: evaluation with contrast material-enhanced subtraction MR imaging. Radiology 1992;185:587-92.
19. Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD. Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol 1992;27:367-73.
20. Verstraete KL, Dierick A, De Deene Y, Uyttendaele D, Vandamme F, Roels H, et al. First pass images of musculoskeletal lesions: a new and useful diagnostic application of dynamic-contrast-enhanced MRI. Magn Reson Imaging 1994;12:687-702.
21. Siegel BA, Donovan RL, Alerson PO, Mack GR. Skeletal uptake of Tc99m-diphosphonate in relation to local bone blood flow. Radiology 1976;120:121-3.
22. Genant HK, Bautovich GJ, Singh M, Lathrop KA, Harper PV. Bone seeking radionuclides: an in vivo study of factors affecting skeletal uptake. Radiology 1974;113:373-82.
23. Yeh SDJ, Rosen G, Caparros B, Benua RS. Semiquantitative gallium scintigraphy in patients with osteogenic sarcoma. Clin Nucl Med 1984;9:175-82.
24. Ramanna L, Waxman A, Binney G, Waxman S, Mirra J, Rosen G. Thallium-201 scintigraphy in bone sarcoma: comparison with gallium-67 and technetium-MDP in the evaluation of chemotherapeutic response. J Nucl Med 1990;31:567-72.
25. Reiman RE, Huvos AG, Benua RS, Rosen G, Gelbard AS, Laughlin JS. Quotient imaging with N-13 1-glutamate in osteogenic sarcoma: correlation with tumor viability. Cancer 1981;48:1976-81.
26. Nagaraj N, Ashok G, Waxman A, Kovalevsky M, Youssim C, Forscher C, et al. Clinical usefulness of serial Tc-99m sesta-MIBI (MIBI) scintigraphy in evaluating tumor response to pre-op chemotherapy in patients with bone and soft tissue sarcomas. J Nucl Med 1995;36(Suppl):129P.
27. Salvatore M, Carratu L, Porta E. Thallium-201 as a positive indicator for lung neoplasms: preliminary experiments. Radiology 1976;121:487-8.
28. Abdel-Dayem HM, Scott AM, Macapinlac HA, El-Gazzar AH. Role of Thallium-201-chloride and Tc-99m sestamibi in tumor imaging. In: Freeman LM, editor. Nuclear medicine annual. New York: Raven Press, 1994,181-234.
29. Ohtomo K, Terui S, Yokoyama R, Abe H, Terauchi T, Maeda G, et al. Thallium-201 scintigraphy to assess effect of chemotherapy in osteosarcoma. J Nucl Med 1996;37:1444-8.
30. Lin J, Leung WT, Ho SKW, Ho KC, Kumta SM, Metreweli C, et al. Quantitative evaluation of thallium-201 uptake in predicting chemotherapeutic response of osteosarcoma. Eur J Nucl Med 1995;22:553-5.
31. Rosen G, Loren GJ, Brien EW, Ramanna L, Waxman A, Lovenbraun S, et al. Serial thallium-201 scintigraphy in osteosarcoma: correlation with tumor necrosis after preoperative chemotherapy. Clin Orthop 1993;293:302-6.